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Abstract
Pain management, end of life (EOL) care, and substance use disorder (SUD) are individually
identified as National healthcare challenges and priorities. Despite 50 years of advances in the
understanding of pain management, pain is still inconsistently assessed and undertreated in all
populations, including those with life limiting illness. When a patient with a life limiting illness
and history of SUD is encountered, pain management becomes further complicated. Effective
pain management for all patients, regardless of coexisting complications, is an ethical obligation
of health care providers. Given the lack of research into EOL pain management of patients with
SUD, it is not surprising that such individuals have been identified as a vulnerable population at
high risk for undertreatment of pain. Additionally, the physical, psychosocial/spiritual care of
this population can be challenging and frustrating, and there are few studies to guide health
professionals in any of these areas. In this qualitative metasynthesis, the findings were derived
from collecting, analyzing, interpreting and synthesizing the qualitative literature from 2010 –
2015 on the phenomena. The findings of this project reaffirm that pain can only be a subjective
experience, and there is no more reliable gauge of pain than the individual’s subjective report.
The findings demonstrate also that clinicians continue to struggle with this subjectivity. The
overarching finding of this project is that the concept of “knowing the patient” becomes even
more significant as the foundation of effective care in the EOL/ SUD patient population. The
combination of the key findings of this project, recommendations concerning pain management
in EOL SUD patients, along with expert clinical knowledge and experience of end of life
interdisciplinary team members, can provide a roadmap for the care of this challenging patient
population.

5
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Pain Management at End of Life when there is a Co-Occurrence of Substance Use Disorder:
a Qualitative Metasynthesis
Introduction
Substance Use Disorder (SUD)
According to the Substance Abuse and Mental Health Services Administration’s
(SAMHSA) 2013 National Survey on Drug use and Health, approximately 24.6 million people
age 12 and over in the U.S. were current illicit drug users/ and identified as having a substance
use disorder (SUD) 136.9 million or 52.2% of individuals age 12 and over in the US were
current users of alcohol; with approximately 60.1 million or 22.9% identifying as “binge”
alcohol users and 16.5 million or 6.3% identified as “heavy” drinkers. SAMHSA estimates that
18 million of these alcohol users have alcohol use disorder (AUD). A number of studies have
shown that alcohol use disorder may be present in up to 28% of cancer patients (Dev, et al.,
2011). It is reasonable to assume that similar percentages of SUD (including AUD) will be found
in the populations entering end of life care. Known negative health outcomes of substance use
disorders include cancer, liver disease, trauma, respiratory disease, overdose, cardiovascular
disease, HIV, STIs, teen pregnancy, fetal damage, motor vehicle accidents, homicide and suicide
(Healthy People, 2020). Crime, domestic violence, financial and productivity loss, school failure,
family system and community disturbance are some of the socioeconomic fallout of the disorder
(Healthy People 2020).
The term “substance use disorder (SUD)” is the DSM-V amalgamated terminology and
criteria for the previously separate diagnoses in the DSM-IV of “substance abuse” and
“dependence”. The criteria are very nearly similar with the exception of the removal of the
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DSM-IV “recurrent legal problems” criterion, and in DSM-V, the addition of the criterion of
“craving” or “desire to use” a substance. Additionally, in order for there to be a diagnosis of
SUD, the DSM-5 sets the threshold that 2 of the 11 diagnostic criteria must be met. The severity
of the disorder is judged by how many of the SUD criteria are met.
Existing vulnerabilities as a result of ethnicity, race, poverty, mental and chronic illness
are compounded by substance use disorder (Walley & Roll, 2007). Caring for individuals with
substance use disorders is challenging and can be frustrating for providers and family alike.
Furthermore, according to Walley and Roll, approximately 45% of patients with substance use
disorder do not believe that their primary care provider is aware of their problem; providers often
fail to use screening tools, and often fail to refer for treatment. As a result, access to care and
quality of care suffer. There is also documentation of mutual mistrust: providers may believe that
the patient will use prescription drugs recreationally or sell them, and patients may expect rapid
results from medications prescribed, have perceptions of mistreatment, or have other unrealistic
expectations of their provider (Walley & Roll, 2007).
Common pitfalls of clinicians in caring for those with substance use disorder include
underdiagosing and undertreating the disorder, poor provider-patient relationships, belief that
treatment success must mean abstinence, that relapse equals failure, and belief that addiction is a
character or moral flaw (Walley & Roll, 2007). According to Oliver et al. (2012) there are four
major conceptual models of substance use disorder which frame treatment direction all of which
may co-exist and overlap:
1. Moral/criminal model sees the individual as morally flawed and socially deviant with
treatment aimed at punishment within the legal system.
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2. 12 step models of treatment see substance use disorders as related to spiritual crisis and
isolation from one’s own values. Individuals are encouraged to follow a lifelong
community based, group approach to recovery and maintenance of sobriety.
3. Disease based model views substance use disorder as a chronic illness. There is a
disorder of dopaminergic pathways affecting the impulse and decision making areas of
the brain resulting in compulsive drug use behaviors.
4. Bio-psycho-social-spiritual model sees pain and addiction as parts of a continuum.
Treatment is aimed at integrating and restoring an individual’s “wholeness”.
Stigmatizing the individual by using terms such as “drug seeking”, “junkie”, “addict”, etc.
interferes with development of a therapeutic relationship and must be avoided (Oliver, et al.,
2012). The overarching successful approach to care of those with SUD may include emphasis on
harm reduction (e.g. needle exchange programs) to decrease the public health and societal
impact. Additionally, there should be consideration of an interdisciplinary team approach, as
studies show that a combination of substance abuse counseling, social work, and psychiatry are
most effective (Walley & Roll, 2007).
Pain
Pain is a common symptom which affects quality of life, contributes to lengthier hospital
stays, readmissions and emergency room visits (American Academy of Pain Medicine, n.d.).
Assessing pain as a “fifth vital sign” was introduced by the American Pain Society (APS) in
1996. This approach has been part of the Veteran Administration’s national pain management
strategy since 1999, and has been accepted as standard practice in many other arenas. The Joint
Commission on Accreditation of Health Care Organizations (JCAHO) pain management
standards for pain assessment and management went into effect in 2001, requiring all healthcare
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providers to appropriately assess and manage pain, and to educate those patients suffering pain
and their families (JCAHO, 2014). Commonly identified barriers to adequate pain management
include fear of addiction, knowledge deficits regarding substance use disorders, knowledge
deficits of pain management in those with a co-occurrence of substance use disorder, and pain
management in general (Morgan & White, 2009). Additionally, fear of hastening death is a
barrier common to pain management in end of life care (Reynolds, et al., 2013).
The 2010 Affordable Care Act required the Institute of Medicine (IOM) of the National
Academies to examine pain relief as a national health challenge and priority, and to make
recommendations. In their report “Relieving Pain in America – a Blueprint for Transforming
Prevention, Care, Education and Research” the IOM reports that chronic pain affects as many as
100 million adults in the US and costs as much as $635 billion yearly in treatment and lost
productivity. Their recommendations include development of a comprehensive strategy to better
assess, treat and understand pain of all types, and to address the regulatory, legal, institutional,
financial and geographic barriers that exist (IOM, 2011).
Effective pain management, particularly in life limiting illness is an ethical obligation of
health care providers (Fine, 2007), and in fact, the Oncology Nursing Society’s (ONS) “Position
on Cancer Pain Management” points out that individuals with active or history of substance
abuse are a population known to be at high risk for undertreatment for pain. Specifically, the
ONS (2013) states: “all people with pain must be recognized, with special emphasis placed on
the populations known to be at high risk for suboptimal pain management (i.e., children…people
with a history of previous or active substance abuse…)”. Further, the position of the American
Society for Pain Management Nursing along with the International Nurses Society on Addictions
(As cited in Oliver, et al., 2012) states: “patients with substance use disorders and pain have the
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right to be treated with dignity, respect, and the same quality of pain assessment and
management as all other patients”. Additionally, according to the American Society for Pain
Management Nursing’s (ASPMN) position statement on pain management at end of life
(Reynolds, et al., 2013) nurses and other health professionals are mandated to alleviate suffering
for every patient receiving end of life care. This mandate by the ASPMN also emphasizes the
need for pain management at end of life for those individuals residing in long term care facilities,
where there is high risk of undertreatment of pain, particularly in those with cognitive
impairment.
End of Life Care
Challenges in quality end of life care include access to care, professional’s education
regarding end of life care and communication, along with ethical and legal debates (Giovanni,
2012). Additionally, there are regulatory barriers, symptom management barriers and for some
health care professionals, both federal and state scope of practice barriers ( DuBois & Reed,
2014). Care management of patients (and family) at end of life when there is a history of
aberrant drug use can be a difficult and complex problem for hospice staff, and raises unique
clinical and ethical dilemmas (Kirsh & Smith, 2008). In the setting of substance abuse, a dying
patient’s pain control can be challenging, families may be chaotic and dysfunctional, and
clinicians may not grasp the impact of addiction on the family unit (Kirsh & Smith, 2008). There
are some who may argue that if an individual has a life limiting illness, SUD should not be
considered (Walsh & Broglia, 2010). Hospice and palliative care clinicians may believe that
efforts to address substance abuse are likely to fail and may even believe that decrease in
substance use is depriving a patient of a source of pleasure. In reality, the chemically dependent
patient’s substance use may be itself a source of suffering and may appropriate care problem for
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hospice intervention (Kirsh & Smith, 2008). Relief of both physical and existential pain,
including the pain and chaos of a SUD must be included in the goals of end of life care.
Opioids are the gold standard for the treatment of cancer pain, but there is controversy
over the use opioids for non cancer pain (Krashin, et al., 2012). Opioid use varies greatly
throughout the world, with the most developed countries averaging 10mg morphine equivalent
per capita per year and less than 0.01mg per capita per year in developing countries (Sullivan &
Howe, 2013). Escalation of prescription opioid sales was seen in the US, beginning in the mid
1980s, and this increase in use in the U.S. also drove an increase in global consumption.
Significant events identified as contributing to the growth of use for pain management was a
cornerstone article by Portenoy and Foley in 1986 on the use of opioids for chronic non cancer
pain (CNCP) followed by the consensus statement in 1996 by the American Pain Society (APS)
on opioid use for chronic pain treatment (Sullivan & Howe, 2013). Subsequently, the passage in
many states of the “Intractable Pain Acts” removed previous sanctions on long term/high dose
opioid therapy. Further, the early 2000s was a time of aggressive opioid marketing by
pharmaceutical companies. A notable example of this marketing blitz was Purdue Pharma’s
claims that Oxycontin was less addictive and less abusable than other pain medications. They
later paid a $634.5 million fine for this claim (Sullivan & Howe, 2013).
Opioids are the mainstay of symptom management in end of life care – and their value is
indisputable. However, there remains a love/hate relationship within the health care community
and aberrant behaviors (dosage escalation, early refills, doctor and pharmacy shopping, lost or
accidently destroyed medications and prescriptions, and frankly illegal activity) cannot be
ignored (Krashin, et al., 2012). In caring for patients with co-occurring pain and SUD, Krashin,
et al. (2012) advise that it is not enough to diagnose the pain condition, substance use and
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psychiatric conditions: there must be thorough assessment of the individual’s total psychosocial
circumstances – including vulnerabilities, strengths and stressors. Patients may have multiple
risk factors for aberrant behaviors around opioid use – including substance use disorder,
pseudoaddiction, confusional states, miscommunication, personality disorders and other mental
disorders (Krashin, et al., 2012).
Purpose Statement
Individually, end of life care, substance use disorders, and pain management are
identified as national healthcare challenges and priorities, and improving the value of healthcare
while reducing cost must be achieved (Fletcher & Panke, 2012). Although over the past 40 years,
there have been advances in the understanding of pain management, pain is still inconsistently
assessed and undertreated in patients with life limiting illness, barriers remain much the same,
and there is real concern and discomfort in health care professionals regarding how to assess and
manage pain especially in the setting of chronic opioid use and when there is fear of substance
use disorder (Gardiner, et al., 2012). When asked, clinicians “know” that “pain is what the
person says it is and exists whenever he or she says it does” (McCaffrey, 1968 as cited in Pasero
& McCaffery, 2011, p.21), but often do not “believe” the patient’s subjective report of pain.
Clinicians may be concerned about drug diversion, “spilled” or otherwise missing medication,
consistent reports of pain as 10/10 despite escalating doses of pain medication, and breakthrough
dosing “on the clock”. Patients may feel “judged”, and may be unwilling to disclose. Addiction
is a disease with many “secrets” and half truths, and can color the interactions in end of life pain
management and care
McCaffery’s 1968 definition of pain was a simple and revolutionary truth. However, in
addition to accepting the patient’s subjective report of pain, the clinician must take into account
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the patient and patient system as a whole, otherwise risk problems in clinical decision making
(Pesut & McDonald, 2007). Perception of pain is a complex phenomena with both physical and
psychological components contributing to the pain experience (Smith, et al, 2007).
There is limited information in the literature regarding pain management in patients at
end of life with a co-occurrence or history of substance use disorder. Initial searches of key
terms “ substance abuse and hospice/end of life care”, “substance abuse and pain management
and hospice and end of life care”, “pain management and hospice” and “pain management and
substance abuse” identify gaps in the literature, the challenges in providing care but no
consensus as to how to care for this special population at end of life. It is the intent of this
project to evaluate the literature by means of qualitative metasynthesis, summarize and interpret
the evidence, and make recommendations for practice.
Theoretical Framework
Margo McCaffery has set the bar for pain assessment and management and her
revolutionary concepts have remained relevant and a gold standard in the compassionate care of
individuals with pain. McCaffery (1990) remarks that when she was in graduate school in the
1960s and wanting to write about pain, she was told by her professor to choose a different topic
because too little was known. Indeed, when one searches the CINAHL data base with the term
“pain” from 1900-1959, 67 articles are identified; from 1960-1999, 24,459 articles are identified;
and then from 2000-2015, 144,469 articles. While tremendous strides have been made since
McCaffery first introduced the concept “pain is whatever the experiencing person says it is,
existing whenever he says it does” (McCaffery, 1968 as stated in McCaffery,Herr and Pasero,
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2011 p. 21) in 1968, pain is still often undertreated and many of the barriers to adequate pain
management identified early on persist today.
McCaffery’s concepts provide a practice framework through which to address the
population in this study: “In the end I think you will realize that [this patient population] you
selected to study has two problems at a minimum, and as a nurse it is your responsibility to try to
help the patient with both. And realize we often fail at both, but we try not to give up. But just
as we cannot force pain relief on a patient who refuses it, we cannot force recovery on a patient
who does not want it or know he needs it (M. McCaffery, personal communication, March 23,
2015)”.
Concepts
McCaffery has advocated for the use of guidelines “formulated by committees of pain
specialists” as well as encouragement for health professionals to accept that the sensation of pain
is completely subjective. She continues to advocate that fears around addiction and misuse can
be decreased with better understanding of the definitions of addiction, tolerance and physical
dependence. Historically, there has been lack of consensus on the terminology used by health
care, law enforcement, regulatory and reimbursement organizations to describe the terms around
SUD, substance use and “addiction”. The following definitions from McCaffery et al. (2011)
help to clarify “misconceptions that hamper assessment and treatment of patients who report
pain” (p.20).
Definitions
Subjectivity of Pain. The sensation of pain is personal and subjective and includes the impact of
an individual’s culture and ethnicity (McCaffery, et al., 2011), and to date there have been no
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more reliable gauges of pain than what the patient says. The “opinions” of the health care
professionals and family members of the patient, as well as measures such as vital signs are not
more valid than the patient’s report of pain. It is the responsibility of the health care professional
to accept the report of pain at face value and take action based on the self report, whether or not
they personally “believe” the patient’s report (McCaffery, et al., 2011).
Pain Threshold. The intensity, duration and character of pain is perceived differently from one
individual to another (McCaffery, et al., 2011).
Pain Tolerance. Tolerance is the maximum intensity or duration of pain that is acceptable to an
individual (McCaffery,et al. 2011).
Behavioral and Physiologic Responses. While the “Acute Pain Model” as described by
McCaffery et al. (2011) states that there will often be objective physical signs of pain –
tachycardia, hypertension, grimacing, frowning, crying, bracing, limping, etc., these are often
short lived and there will be behavioral adaptation or other suppression of pain behavior.
Simultaneously, an individual with pain may alter their behavior to meet the expectations of
what a person in pain “should” look like. This is often interpreted by a clinician as manipulative
but it may be brought about in the first place by the clinician or societal expectations of how the
person in pain should behave (McCaffery,et al.2011). The sleeping patient is also an individual
who may be mistakenly identified as having no pain (McCaffery, et al., 2011).
Causes of Pain. Cause of pain may or may not be able to be determined. Available assessment
tools may not tease out the problem, but just because a cause cannot be established, it does not
mean that the patient does not have pain (McCaffery, et al., 2011). Approximately 50% of
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patients with unrelenting pain may also have depression or anxiety disorder, and considerable
interference with quality of life (McCaffery, et al., 2011).
Addiction. Addiction may be defined as a chronic biologic neurologic disease with
environmental, psychosocial and genetic components. Behaviors may include compulsive use of
a substance, impaired control craving, and continued use of the substance despite negative
consequences (McCaffery,et al., 2011).
Physical Dependence. This is a normal physiologic response to use of opiates and is a state of
adaptation that results in symptoms of withdrawal if the agent is stopped abruptly (McCaffery,et
al., 2011).
Physical Tolerance. This is a normal physiologic response to use of opiates resulting in
decreased analgesia, decreased sedation and/or decreased respiratory depression. If pain is stable,
this ordinarily results in stable doses, and the need for increased dosing may be primarily related
to disease progression, not tolerance (McCaffery,et al., 2011).
Pseudo Addiction. When a patient’s pain is under treated, they may behave in a way that is
consistent with addiction (e.g. deception, illicit drug use, clock watching, escalating demands,
etc.), however behaviors resolve once pain is treated effectively (McCaffery,et al., 2011).
Impact of Personal Bias. Physical appearance, gender, age, race/culture, personal pain
experiences, “ ‘irresponsible’” lifestyle all may impact a clinician’s beliefs about an individual’s
report of pain, and lead to inadequate pain management. It is incumbent on all clinicians to
identify and strive to overcome their biases (McCaffery, et al., 2011).
Additional points
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Opioids are unlikely to hasten death in an opioid tolerant patient (McCaffery, 1995).
Further, adequate pain relief does not cause respiratory depression (McCaffery, 1995). And
finally, regarding opioids, addiction and the terminally ill, McCaffery quotes the American
Cancer Society and National Cancer Institute: “‘Pain relief is a medical reason for taking
narcotics. Therefore, if you take narcotics to relieve your pain you aren’t an addict no matter
how much or how often you take narcotic medicines’ (McCaffery, 1995 p.61)”.
Applicability of McCaffery’s Practice Framework
Technological and research fueled therapies have turned many “terminal” diseases into
chronic conditions and dramatically increased length of life; and for many, quality of life as well.
Even so, in late stage disease management, eventually all the sophisticated life prolonging
measures are stripped away, as their usefulness passes. What actions then can be taken? What is
left to “do”? How do we address the anger of a patient’s loved ones who have unrealistic
expectations of the healthcare system, or have no understanding that our human machinery truly
reaches a point where there is no curative intervention? It is at this juncture that the real question
often becomes are we saving life, or prolonging suffering?
Quality care at end of life always comes down to a series of “decision trees” of sorts, and
choosing and releasing interventions in order to find the unique path or solution that affords the
greatest good at the time. The practitioner must step back and support patient and family to reestablish goals and re-define quality of life and roles, ideally utilizing an interdisciplinary
approach. Sometimes “healing” becomes a psychosocial or spiritual journey, creating a healing
environment, or supporting an individual’s self healing. Sometimes it can become aggressive
physical symptom management, and sometimes it is simply providing therapeutic presence and
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witnessing the existential suffering. Being “present”, being part of a patient and family journey
and acting as a healing guide through the journey is basic to effective end of life care.
The complexity of pain and symptom management in end of life care coupled with a cooccurrence of substance use disorder requires innovation, development of trusting relationships,
personalized intervention and mutual goal setting. The practice framework supplied by
McCaffery’s teachings on pain assessment and management provide a structure and lens
through which to view pain in the terminally ill patient with a co-occurrence of substance use
disorder.
Description of the Relevant Literature
A turning point in the scientific interest in the study of pain began with the proposal of
the gate control theory of pain in 1965 (Robert, et al., 2010). Using that date as a starting point,
when one searches the term “pain management” in the CINAHL database there is one lone
article identified in the year 1965. By 2014 this number had risen to 906 articles published for
the year. Interestingly, using the year 1965 again as a datapoint, when one searches the
individual terms “substance abuse” and “drug abuse” as well as “hospice” and “terminal illness”,
no publications are found. By the year 2014, however, 2007 articles on “substance abuse” and
699 articles on “hospice” can be found. It has been clear from this author’s search of the
literature in CINAHL and multiple other databases that there has been a paucity of knowledge on
these phenomena and that these fields are underdeveloped separately and even more-so as cooccuring phenomena.
A bibliometric study on the evolution of the scientific literature on pain between 1976
and 2007 by Robert, et al. (2010) showed 6 fold growth in the number of articles on pain with
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the number of journals specifically dedicated to pain growing from 2 in 1976 to approximately
40 in 2007. Additionally, there has been tremendous increase in the number of countries
participating in pain research, with the EU surpassing the US in terms of productivity. Despite
this impressive growth, the science is young and dissemination of the literature to practice has a
considerable way to go. There remains an underemphasis in the education of health professionals
(in particular the prelicensure education) which represents a major barrier to effective pain
management in all populations (Fishman, et al., 2013). From the work of the Summit for
Interprofessional Consensus on Pain Management Competencies, Fishman, et al. (2013) have
defined a set of consensus driven core competencies encompassing four domains – including the
nature of pain , assessment and measurement, pain management and the context of pain
management, along with values and guiding principles within each domain. The universal nature
of these competencies are to be applied across settings, populations and models of care and
address the needs of children, adults, acute and chronic pain and pain at end of life. However,
there is considerable challenge now to incorporate this work into educational curricula and then
into practice.
Anderson (1982) utilizing nursing process as an organizational framework looked at an
international review of the literature on the cancer patient in pain. This vintage paper from 1982
was one of the first of its kind to systematically review the pain management literature. Anderson
identified that there were relatively few studies on the subject of pain and that there was a great
need for more research in order to “help cancer nurses recognize their unique role in pain
assessment and management for cancer patients”(p.33). Since that time, the study of pain
management has expanded, but there is much work to be done. A systematic review by Minozzi,
et al. (2012) concluded that use of opioid analgesics for chronic pain are not associated with an
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increased risk for addiction. However, the authors cite as their most impressive finding the
deficiency of good quality studies on the subject of pain and opioid analgesics, given the
widespread concern by many regarding the use of opioids for managing pain.
While there are many descriptive articles, nursing is under-represented in the pain
management research literature. In a review of select studies and literature between 1979 and
2007, Morgan & White (2009) summarized results about nursing knowledge on the topic of
“pain and addictive disorder”. They found that much of the literature of the late 1990s and early
2000s on co-occurring pain and addictive disorders primarily concerned the HIV/AIDS
population and those in methadone maintenance programs. Their findings document an
historical lack of education on the subject of pain management and addictive disorders in general
as well as an atmosphere of “opiophobia”. They further found nurses to be more “punitive,
negative and authoritarian”(p. 46) towards patients with addictive disorders, but that although
they demonstrated marginalizing and stigmatizing behaviors, nurses felt guilt and shame over
their own responses and judgmental behaviors.
In a study by Wilson (2009), which in part replicated the classic 1992 “Ben & Mike”
simulation study by McCaffery and Ferrell, where two groups of nurses were presented with two
clinical scenarios where the socio-economic status of the two patients was manipulated, while all
other characteristics and data remained constant. “Mike” was a businessman and “Ben” was a
construction worker and unemployed. Their simulated clinical histories were exactly the same,
with both having sustained injuries in a traffic accident and were in pain, the only difference
between the two was their socioeconomic status. The intent of the assessment of these two
hypothetical patients was to demonstrate how patient characteristics might influence pain
management decisions.. The vignettes were similar in the Wilson (2009) study, however, the
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two groups of nurses were generalist and hospice nurses. The participants were required to fill
out a questionnaire addressing pain knowledge, pain inferences, general attitudes and beliefs
about pain management as well as to identify the patients’ pain level and make decisions about
pain management. The generalist nurses undermedicated but were very concerned about
respiratory depression, tolerance, and addiction. The hospice nurses were found to be less biased
about lifestyle, but also undermedicated the patients in the scenarios. The conclusion was that
current educational and clinical experiences of all nurses was insufficient to erase bias and myth.
On a more positive note, in a survey of 145 VA nursing staff, Goebel et al. (2010)
reported that nurses with more experience, higher education levels, and with documented higher
levels of self efficacy and self confidence were more likely to discuss addiction fears with
patients concerned about the effects of pain medication than less experienced staff. Goebel et al.
(2010) further recommended that efforts to improve pain management should also include focus
on the retention of experienced nursing staff.
Health care professionals may “know” but may not “do”. A case in point is in the use of
common pain assessment/screening tools. A 2010 VA funded cross sectional visit based cohort
study with survey by Shugarman, et al. (2010), evaluated factors impacting 94 nurses and other
staff use of pain assessment tools with 465 patients during routine visits. They found that
underestimation of pain occurred in 25% of encounters, and overestimation in 7%. In half the
encounters, staff did not follow pain assessment protocols or use mandated tools. Again, rather
than believing that nurses were noncompliant, unmotivated employees, one could conclude that
there are inadequacies in the standard pain assessment tools, or that there might be other system
failures.
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Barriers to adequate pain management span 40 years of literature. A 2006 survey by
Fineberg, et al. identifies that despite hospital guidelines supporting unrestricted opiate
administration to treat end of life pain, as well as clinician support of the concept, pain was often
undertreated. Common causes for undertreatment were system barriers, knowledge deficits about
pain management and institutional policy, and personal bias. In a cross sectional multicenter
study of 525 patients with cancer diagnosis by Anton, et al. (2012), the topic of inadequate pain
management despite availability of effective analgesics was addressed. Patient attitudes and
beliefs around pain and use of analgesics impacted their pain management, and patient
perception of pain was highly influenced by communication with as well as information
provided by the health professional. Those who were dissatisfied with their pain relief stated they
were not asked as frequently about their pain and felt that their physicians were less involved.
In a quantitative descriptive cross-sectional survey study looking at barriers to cancer
pain management in oncology nurses in Jordan (Al Khalaileh & Al Qadire, 2012), concerns of
nurses were abundant despite clinical knowledge and education. There was a view that
management of cancer pain was futile, devaluing patient reports of pain. and generally, that pain
medication is more harmful than beneficial. In a survey of patients with advanced cancer by
Miccinesi, et al. (2012) looking at end of life preferences, pain and dyspnea were the two
symptoms most often reported as intolerable, and the majority of patients stated that use of
opioids was acceptable although some routes of administration were less desirable. Biases
around addiction and attitudes were linked to the amount of dialog with physicians.
A systematic review by Lorenz, et al. (2008) provides review of the evidence of
interventions to improve palliative and end of life care. This study also looked at the literature
from 2005-2007 and includes articles addressing end of life and interventions to address pain,
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dyspnea, depression, advance care planning, continuity of care, and caregiving. The diagnoses
focused on in this study were cancer, chronic heart failure, and dementia. The authors evaluated
the strength of the evidence and rated study design utilizing the GRADE system, scoring the
evidence as high, moderate, low, or very low. After identifying 24,423 titles, ultimately 33 high
quality systematic reviews and 89 intervention studies were included. This robust study reported
numerous research gaps/weak evidence for managing non cancer pain, dyspnea, depression, and
insufficient evidence for addressing dyspnea in cancer and heart failures. They identified a need
for further research in spiritual/bereavement domains as well as technical interventions such as
palliative surgery, etc. They identified strong evidence for treating cancer pain with
nonsteroidals, opioids, radio nucleotides and radiotherapy. They identified strong evidence for
treating dyspnea with beta agonists and opioids in COPD and strong evidence for psychotherapy
and antidepressants when there is a cancer diagnosis.
A review of complementary and alternative literature by Running and Turnbeaugh (2010)
provided exploration of the evidence on the effectiveness of complementary therapies (CT) and
cancer pain and symptom control. They searched the literature for studies of prevalent types of
pain described by patients with cancer – bone, chronic, neuropathic, and visceral. They
classified the studies by level of evidence. Of all the modalities, they noted that massage therapy
and energy therapies have shown some effectiveness in cancer pain management but there needs
to be further trials with larger number of participants in order to evaluate efficacy. They
cautioned that CTs should not be relied upon for total pain control and that use of integrative
approach with both CT and pharmacological therapy may be more beneficial than
pharmacological treatment alone.
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Consensus in terminology has been a stumbling block in the study of “substance use
disorder” (SUD, the DSM-V amalgamated term for the DSM-IV terms “substance abuse” and
“dependency”) as well as the pain management literature. Knudsen, et al. (2009) provided a
systematic literature review to identify the classification systems used to classify cancer patients
with pain. They looked at 692 papers covering a 20 year span. Of these, 92 papers were included
for further analysis – 55 clinical studies and 37 educational papers. They found that there was no
international consensus on the 6 classification systems identified. And of these, three
classification systems were classified as partially validated and they noted that none were
consistently or widely applied. They pointed out a need to develop an international consensus on
how to classify pain in patients with cancer. They projected that development of a “cross
culturally robust international system that is evaluative, descriptive and prognostic” (p.305) will
lead to better control of cancer pain.
Examining the terminology of pain, physical dependence, pseudo addiction, and
addiction, Bell and Salmon (2009) critically evaluated “discourses on pain management and
addiction” written by and for physicians. They found in the literature a desire to overcome
opiophobia by separating the consequences of “proper” use of opioids for “legitimate” patients
as opposed to feeding addiction, and an attitude of the “deserving pain patient” vs. the
“undeserving addict”. They pointed out that a dichotomy exists - that while pain is assessed via
subjective reports, clinicians are often warned not to trust a patient’s self report. Further,
physicians are essentially being asked to be the moral and legal gatekeepers. They also remarked
on the challenge for physicians in deciding whether or not to prescribe opiates for pain in the
setting of potential pseudo addiction. Further, they suggest that pseudo addiction is perhaps
simply a sanitized syndrome of pain patients who are white, middle class, and do not have (or do
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not appear to have) a history of substance abuse. They further outlined that because of the
economic costs of pain, proper pain relief is tied to a patient’s economic worth as productive
member of society. They summarized that the discourse in the literature on the subject of pain
and addiction only serves to further stigmatize “the addict” and undermined access to adequate
pain management.
Prevalence of opioid use for chronic non cancer pain management (CNCP) has increased,
leading to controversy and challenges. Edlund, et al.(2010) noted that opioid use for chronic non
cancer pain was on the increase in their analysis of prescribing trends between 2000-2005 in
commercially insured patients covered by Medicaid. They further pointed out the impact of cooccurring mental health diagnoses and/or substance use disorder. For the commercially insured,
chronic opioid use increased by 34.9% in individuals with mental health diagnoses and/or
substance use disorder, as opposed to 27.8% in the population without these disorders. They
further noted that in those insured by the Medicaid system, chronic opioid use increased by
55.4% for those with a mental health or SUD and by 39.8% in those without diagnosis of these
disorders.
While some believe this is a sign of improved pain management, others see this as a
concerning trend. In a mixed methods exploratory study looking at the acute pain management of
those with SUD in the acute hospital setting Blay, et al. (2012) concluded that because of altered
responses to analgesia, differences in cultural values, and health professionals perceptions, the
SUD population is truly different, and that they require “significant deviation” from pain
management protocols. In a review of recent literature on acute and chronic pain in patients on
methadone maintenance and addiction treatment, Eyler (2013) concludes that pain responses in
patients on methadone maintenance are different from those patients who are not, and the pain
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medications for these patients may also differ significantly. She identified that opioid induced
sensitivity to pain is long lasting in this population, and the presence or absence of chronic pain
may impact their perception of acute pain. Interestingly, gabapentin has been used successfully
to reduce this sensitivity in some patients. Eyler (2013) further emphasized studies
demonstrating the “underlying tension” between prescribers and patients around the subject of
pain management with underlying opioid addiction. She concluded with recommendation of the
need for rigorous studies to inform health care providers regarding effective pain management
approaches for this population.
Wachholtz, et al. (2015) examined key empirical and theoretical papers on the
relationship between hyperalgesia,tolerance, and the use of opioids. They acknowledged that
research on differences in the psychophysiology of patients with pain and opioid misuse
disorders is in the early stages – but suggest that alterations in psychophysiological pathways
may be present in patients with SUD. These alterations may result in greater levels of
hyperalgesia, and hyperalgesia may develop as early as a month after beginning use of short
acting opioids. They noted too that some have hypothesized that addiction and hyperalgesia may
come from the same area of the brain. They called for continued research to develop novel,
integrated treatments for these complex patients.
In a large, older study, based on data from the Danish Health and Morbidity Survey,
Eriksen, et al. .(2006) concluded that while opioids improved CNCP, function and Quality of
Life (QOL) for some, there was no consensus. They also stressed that the increase in opioid use
was not only the result of clinical need and recommendations from pain experts, but also the
result of sales promotion activities by pharmaceutical companies.
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Use of opioids with abuse deterrent formulations, such as the addition of naltraxone, is
promoted by some. Pade et al. (2012) call the abuse of opiates a “public health crisis” and call
for new approaches to treat patients with CNCP who also have SUD. They report on the
development of a “co-occurring disorders clinic” to treat patients simultaneously for chronic pain
and addiction in a VA clinic system in New Mexico. Co-occurring opioid dependence and
chronic non cancer pain (CNCP) were treated with bupenorphine/naloxone . In their
retrospective chart review, including state prescription monitoring and random urine drug
screens, their results demonstrated modest success with patient compliance, pain relief, and
relapse.
Similarly, Ling, et al.(2011) citing case studies, recommended that physicians find a
balance between limiting potential adverse effects of opioids while maintaining their “legitimate
access” for treatment of pain. They further called for research directed at abuse deterrent
formulations and research on genetic risk factors for opioid dependence and hyperalgesia.
Michna (2014) in a metaanalysis sponsored by Pfizer searched PubMed and Cochrane Library
databases to compare the safety and efficacy of opioids with and without abuse deterrent
formulations. The findings demonstrated comparable efficacy profiles.
Concern is expressed by some regarding the misuse of opioids in patients with cancer
diagnoses. Starr, et al. (2010) in a descriptive article stated that even in patients with a terminal
cancer diagnosis, 50-60% survive at least two years which can lead to problems for those with
history of addiction. They call for consensus between clinicians regarding opiate prescribing
practices, addiction screening, and use of effective pain assessment and documentation tools.
Similarly, Koyyalagunta, et al. (2013) in a retrospective analysis of patient records, noted that
with improved cancer survival and prolongation of life there is greater opportunity for opiate
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misuse. They reported that their findings are similar to the findings of other studies looking at
risk factors for opioid misuse in patients with chronic pain – that is, those who are younger, have
co-occurring anxiety and depression are at higher risk. They also noted that the literature on the
care of the cancer patient with a history of SUD is scant. They recommended adopting a risk
stratification system that would trigger further assessment of patients found to be at higher risk.
Noting ongoing debates about addiction and use of strong opioids in relief of cancer pain,
Smith et al. (2007) in a small literature review researching “the controversial issues” contributing
to poor pain control, found that patients without previous chemical dependency are rarely
“addicted” to pain relievers. These researchers recommended that education be current and
ongoing – especially for the generalist staff. Further, they recommended that there needs to be
improved and excellent assessment skills, and finally that use of the World Health Organization
(WHO) analgesic ladder may not be appropriate for this patient population. Gaertner and
Schiessl (2013) emphasized that patients suffer because available options for cancer pain
treatments are underutilized. They looked at guidelines, meta-analyses, systematic reviews,
treatment recommendations and articles from 2012 for review of findings, treatment
recommendations and controversies in cancer pain management – including new agents, efficacy
of older/established agents and conflicting recommendations from guidelines. Their primary
conclusions were that new pharmacologicals hold promise for treatment, but the gold standard
must be establishment of early palliative care as an integrative, multi-professional,
interdisciplinary collaboration.
Blackhall, et al. (2012) expressed concern that the problem of potential SUD and
diversion in hospice must be addressed at the policy level. They reported a lack of information
in the literature documenting how hospices should address SUD in hospice patients and their
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families. Their survey of Virginia hospices demonstrated that less than half of the hospices
surveyed had mandatory substance abuse training and policies. Only 38% of those surveyed felt
that SUD and diversion were problems for their agencies – which seems to be an optimistic
view. The authors called for research into the topic and for guidelines to address management of
SUD and pain at end of life
For 40+ years there are recurrent recommendations for research and education on the
topic of opiate pharmacology and prescribing, pain and addiction. However, very little has been
written on these topics in setting of life limiting illness. Goldstein and Fischberg (2008)
provided a review of 17,000 citations distilled down to a handful of quality studies regarding
pain management, non pain symptom management, nursing home care, prognosis, and quality of
care within palliative care. Conclusions of key individual studies were documented and
reiterated some “bottom line” clinical suggestions – among them: stop withholding opioids at
end of life – as there is no evidence that opioids hasten death or cause other harm.
In this literature review, representative quantitative and mixed method studies including
systematic reviews, underscore the clinical challenges and issues in pain management, SUD and
life limiting illness. The existing quantitative and mixed method literature is not able to
adequately address the central topic of this project and provides no consensus as to how to
manage pain and provide comprehensive and compassionate care of this population at end of
life. In this project, metasynthesis of the recent qualitative literature will provide additional
compelling evidence upon which to base recommendations for practice and further research.
Methods
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Project Design.
High quality systematic reviews are the gold standard for summary of evidence in the
literature. They can minimize bias and improve reliability of conclusions on which clinical
practice guidelines can be based (Riesenberg & Justice, 2014). The systematic review makes
clear what is known and not known on a given subject and the systematic review is relied upon
heavily to inform clinical decision-making (IOM, 2011 as stated by Riesenberg & Justice, 2014).
Methods for developing the evidence base in end of life care must be rigorous and must reflect
the complexities of caring for this population. Some research with biological/quantitative
outcomes may be of value – for instance tumor response in patients receiving palliative care.
However, a more effective measure of interventions in palliative care may be whether an
individual or family perceive improvement in quality of life, feel better overall, feel supported or
otherwise perceive a good outcome (Fleming, et al, 2008). Thus, qualitative inquiry can be
especially useful in addressing the constructs of living with and managing the effects of disease,
the personal and cultural meaning of disease, end of life decision making, as well as the
political, historical, cultural context impacting access to care, health promotion, disease
prevention, and health disparity (Sandelowski & Barroso, 2007). The synthesis of qualitative
research aims to review and integrate the findings of qualitative studies to inform practice and
may include thematic descriptions or interpretive explanations of the research. I decided with my
project chair that the best strategy to inform practice on the topic of pain, SUD and EOL, given
the dearth of literature, was to undertake a qualitative metasynthesis.
A qualitative metasynthesis is defined by Sandelowski and Barroso (2007) as: “…an
interpretive integration of qualitative findings in primary research reports that are in the form of
interpretive syntheses of data: either conceptual/thematic descriptions or interpretive
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explanations”(p.199). For guidance on the mechanics of a qualitative metasynthesis of nursing
research, we utilized Sandelowski & Barroso’s Handbook for Synthesizing Qualitative Research
(2007). This reference provided direction on utilizing qualitative methods to analyze and
interpret the data and then integrate and synthesize the findings.
Investigative Techniques
A five phase approach was utilized to collect, analyze, interpret, and synthesize the
qualitative literature on the phenomenon. In a metasynthesis, the findings are derived from
taking all the studies and viewing them as a whole. It is not a summary of unlinked data, but
instead an integrated interpretation and explanation of the data around a phenomenon
(Sandelowski & Barroso, 2007).
Phase I comprehensive retrieval of the literature. Temporal, topical and
methodological parameters were defined for the literature search process. Beginning 9/1/14 and
ending 2/15/15 multiple electronic data bases were used to search multiple terms. Initial searches
confirmed prior searches of the literature, revealing that there is very little written on the specific
topic of “pain and end of life when there is a co-occurrence of substance use disorder”, and
minimal qualitative studies. It was determined that the best strategy to inform us on the project
topic was to look at similar phenomena using different combinations of search terms. So the
literature search was broadened to look at the topic elements in any combination (e.g. pain+SUD,
pain + EOL, SUD +EOL).
As the process unfolded, search terms were modified to yield more titles. Footnotes and
references of relevant studies and articles were reviewed for potential retrieval of yet more
studies. Names of individual authors were searched in an attempt to retrieve more published
work on the phenomena. Citations and abstracts were appraised for relevance, and if the study
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found was qualitative or mixed method and informed on at least two of the combined topics of
pain, substance use disorder, and end of life, they were initially selected. This process was fairly
exhaustive and the combined citations reviewed exceeded 1000 titles. If the title was found to be
relevant to the phenomenon, the abstract was read. If the abstract proved significant, the full
study was reviewed. At that point, a study was included, excluded, or set aside for further
review. While the searching was extensive, the actual number of relevant qualitative studies
identified was relatively small.
Phase II selection of studies, initial analysis. Finally, 38 studies were included in this
project. A weighted “quality appraisal” per se was not undertaken in the selection of studies.
Synthesists argue against having a “checklist mentality” when evaluating the “quality” and
usefulness of qualitative research, and that the “quality” of a study should be treated as simply
one of the characteristics (Sandelowski & Barroso, 2007). The studies included were those
studies from 2010-2015 written in English, found in peer reviewed journals, and were either
qualitative or mixed method with heavy qualitative content where the qualitative findings could
be separated from the quantitative. We did accept several systematic reviews which captured
earlier literature on the topics. Sandelowski and Barroso (2007) point out that the “the major
device enabling comparative appraisals is a data display showing the same key elements of
information in each report together” (p.79). For this project, the theoretical/conceptual
framework, research question/hypotheses, methodology, results, conclusions/themes/key points
and significant quotes from each study were manually summarized in a matrix to facilitate
appraisal.
Initial analysis and comparison of the studies identified that they yielded data from the
distinct individual perspectives of the patient, nurse, physician/prescriber, family/caregiver and
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society. After further examination, we found that the studies could secondarily be catorized by
at least 2 of the three phenomena of interest: EOL and Alcohol/Illicit Drug Use; EOL and Pain;
Chronic Non-Cancer Pain; Opiate Dependency and Pain; and Cancer Pain Management. The
studies were re-ordered, grouping by these pain/substance use disorder/EOL themes and then
analyzed again from the “voice” of each perspective (patient, nurse, physician/prescriber,
family/caregiver - the one study from societal perspective fell within the theme of “Cancer Pain
Management” only).
Phase III interpretation of the literature. The search for recurrent themes in data and
the integration of themes into a unifying concept is foundational to qualitative inquiry
(Sandelowski & Leeman, 2012). In a metasynthesis, the researcher is able to integrate the
findings of studies and describe or explain the phenomenon and “craft one or more
metasynthesis…their validity does not reside in a replication logic but rather in an interpretive
logic, whereby findings are reframed…(Sandelowski & Barroso, 2007 p. 152)”. In this project,
we were looking at the literature for an integrated whole from which we could inform the
practitioners who work with this population. Between 9/1/14 and 3/22/15, my Project Chair and I
met at regularly scheduled intervals in person and electronically for research and interpretive
sessions. Separately and then together, we examined emerging themes from the selected studies
and the relationships between themes. A “taxonomic analysis” was undertaken as a strategy to
further capture and penetrate the findings of the selected studies. Findings were extracted from
each pain/SUD/EOL theme category (EOL and Alcohol/Illicit Drug Use; EOL and Pain; Chronic
Non-Cancer Pain; Opiate Dependency and Pain; and Cancer Pain Management) and from each
perspective (patient, nurse, physician/prescriber, family/caregiver and society). The resulting
document “Taxonomy of Findings” provided a platform to further examine themes. This process
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was inductive and interpretive. Thematic analysis and interpretation continued until saturation
and integration was reached.
Phase IV synthesis of key findings. Ultimately, the interpretive synthesis of the data
yielded four key findings: the overarching theme of “knowing the patient”, along with “fear”,
“system barriers”, and “mutually exclusive rituals between health professional and individual
with SUD”.
Phase V recommendations for practice, and recommendations for future research.
Sandelowski &and Leeman (2012) recommend that in order for the findings in qualitative health
research to be more significant and actionable, the findings must be presented in the language of
intervention and implementation. The final phase summarizes how the findings of this project
inform practice when caring for a patient at EOL with SUD, as well as making other practice
recommendations and recommendations for further research.
Rigor
Sandelowski and Barroso (2007) emphasize a focus on descriptive, interpretive,
theoretical and pragmatic validity in order to assure valid procedures and outcomes. Descriptive
validity was maintained by ensuring an extensive and exhaustive search of the literature and by
accurately appraising the information in the studies utilized. Interpretive validity was maintained
by accurately representing the points of view of the researchers in the studies utilized.
Theoretical and pragmatic validity of the methods utilized in this project were assured by holding
regularly scheduled research meetings and interpretive sessions, by having both the DNP student
and Project Chair (who has expertise in qualitative research methods) appraise the identified
literature and by ensuring an “audit trail” of the processes and the studies was utilized.
Human Subjects
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No human subjects were involved in this project, and this qualitative metasynthesis is
identified as “exempt” per Section 3.5.2.C of the Policy & Procedures for Research with Human
Subjects at California State University, Fresno. Evidence utilized has been wholly from the
existing published literature in the areas of interest in this study.
Discussion of Key Findings
Key Finding #1, Knowing the Patient
The importance of “knowing the patient” in the setting of pain, end of life, and substance
use disorder is the overarching finding of this qualitative metasynthesis. What it means to “know
the patient” requires cultural competency, understanding of their worldview, awareness of their
“currency”, strengths, challenges, what they see as elements of a good quality of life as well as
barriers to obtain that quality of life (St. Marie, 2013). Understanding the meaning of and
barriers to good quality of life (QOL) is particularly important in order to gain knowledge of the
individual living with pain, with or without life limiting illness, and with or without SUD.
Elements of good quality of life include pain relief, to feel “normal”, to be able to function, live
life unafraid and meaningfully, with meaningful relationships, and to have hope for the future
(DeMaeyer, et al., 2011). Additionally, the individual living with pain wants to be understood,
to be listened to empathetically, respected and to not be judged for their actions around pain
relief (McCreaddie, et al., 2010). They want to be heard when they share information and
believed when they say they are in pain (Esquibel & Borkan, 2014). Individuals with history of
SUD do not want to be spoken of in stigmatizing terms such as “addict”, “drug seeking”,
“junkie” (St. Marie, 2013).
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Barriers to good quality of life for individuals with substance use disorder can include unor undertreated physical and existential pain, the loss of health, and fear of an impending and
early death (Dzul-Church, et al., 2010). Drug craving and fears around withdrawal often lead to
deceptive behaviors, which in turn undermine relationships; yet loss of key relationships and the
resulting isolation are consistently, identified as significant barriers (Roe, et al., 2010). A chaotic
lifestyle that includes illegal activities may increase stress and anxiety (McCreaddie, et al.,
2010). Co-occurring mental illness further disenfranchises individuals, impacts QOL, and is seen
as a barrier to effective pain management as a result of the difficulties in distinguishing what
contribution each condition has to the patient presentation (Barry, et al., 2010). There may also
be limited access to health and social services (Dzul-Church, et al., 2010), which impacts QOL.
In a 1993 study, Tanner & Benner described “knowing the patient” in terms of expert
nursing practice – knowledge that moves beyond empirical data about the patient to an in depth
understanding of the patients patterns of responses, and knowing “the person”. The findings of
this qualitative metasynthesis are in harmony with this concept. Health care providers must be
aware of their own biases and blind spots as well as the potential for conflicting priorities. In
developing the therapeutic relationship, the health care provider must set the tone for openness,
transparency, honesty, and connecting with patients with SUD “as people not problems”
(McCreaddie, et al., 2010, p.2738). They must effectively communicate, anticipate needs and
problems, and take the time to be truly present in patient interactions (Browall, et al, 2014).
There must be goal setting and mutual expectations outlined. Strengths and inner resilience must
be validated and supported (Roe, et al., 2010; Dzul-Church, et al., 2010). Pain must be
addressed within the patient’s subjective cultural and social constructs (Hazous & Knobf, 2014;
Luckett, et al., 2013). Further, the health care provider must be educated in pain management,
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end of life care and how the disease of SUD impacts the interactions (Simone, et al, 2012).
Being open to harm reduction strategies and improved educational preparation of the generalist
health professional on pain, end of life care and SUD is key (McNeil & Guirguis-Younger,
2011).
Individuals have a need to give meaning to their actions, especially hidden behaviors
such as substance abuse (Rigg & Murphy, 2013) and underserved individuals with substance use
disorder at end of life may require greater understanding by health providers of the impact of
their life stories on their current reality (Dzul-Church, et al., 2010). However, whether or not
there is a history of SUD, pain exists within the individual’s cultural and social context and the
subjectivity of their pain experience is undeniable (Luckett, et al., 2013). Pain may impact every
aspect of an individual’s life and may lead to feelings of anger, frustration, sadness, despair,
powerlessness, helplessness and loss of control. And significantly, for the individual with life
limiting illness, pain may signal a worsening of the underlying disease process (Luckett, et al.,
2013). The individual is the ultimate expert about their own pain, and what pain means to them
must be appreciated (Knudsen, et al., 2012).
Key Finding #2 Fear
“How very little can be done under the spirit of fear… (Florence Nightingale as stated in
Cipriano, 2015)”. However, fear of personal or professional negative consequences or
punishment can be a powerful motivator of behavior. In the findings of this project, each
perspective – Patient, Provider/Prescriber, Nurse and Family/Caregiver displayed a unique
combination of fears, although there were fears that these groups had in common.
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Each group was identified as being fearful of addiction (Luckett, et al., 2013). The
patients with SUD were fearful of craving and of withdrawal (St. Marie, 2013). Patients had a
fear of the unknowns in their future, fear of their personal “core” being exposed and vulnerable
(Dzul-Church, et al., 2010). They were fearful of pain and of death (St. Marie, 2013) and of the
side effects of pain medications (Coker, et al., 2010). Patients and caregivers both were fearful of
pain, and were both also fearful of disease progression (Flemming, 2010). Both nurses and
caregivers were fearful of overmedicating (Coker, et al., 2010), and fearful of not being able to
provide relief (Flemming, 2010). Caregivers were fearful of undermedicating as well (Luckett,
2013). Nurses and Provider/Prescribers were fearful of being judged by their peers, and both
groups were fearful of litigation (Zerzan, et al., 2011). Provider/Prescribers felt the weight of
potential consequences around prescribing opiates by DEA and licensure (Zerzan, et al., 2010),
and were also fearful of prescribing opiates due to lack of familiarity (Gardiner, et al., 2012).
Key Finding #3, Mutually Exclusive Behaviors
The patient with SUD and pain; and SUD, pain, and a life limiting illness most often
present in the primary care or emergency department – not into a setting with a high degree of
expertise managing any of these three conditions. There may be a mismatch in perceptions and
expectations of the therapeutic relationship (Luckett, et al., 2013). Clinician rituals and routines
tend to be organized and efficient, authoritative, and in control (McCreaddie, et al., 2010). The
clinician may perceive those with SUD as immoral, responsible for their health outcomes
(DeMaeyer, et al., 2011). In contrast, the patient who has a SUD may mistrust the healthcare
delivery system – and then act in a way that demonstrates this mistrust – e.g. medical noncompliance, aggression, and self discharge (McCreaddie, et al., 2010). For the clinician, the
priorities of care may be treatment of the underlying disease, safety, prevention, and compliance
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with regulatory bodies and employment systems . Provider/Prescribers and nurses who are
unfamiliar with the management of pain in a patient with SUD may be caught off guard by the
conflicting priorities and potential for deception, chaotic, and potentially illegal activities (such
as diversion, illicit drug use, criminal activity to obtain illicit drugs, etc.) which contrast with the
rules, regulations and timeliness pressures of the “mainstream” health care delivery system
(McCreaddie, et al., 2010). However, the behaviors used to obtain medications allow the
individual with SUD to prevent withdrawal – which may be their priority (McCreaddie, et al.,
2010). The individual with SUD may conceal information (St. Marie, 2014), while the clinician
needs transparency in order to plan effective care. There may be what is perceived as mismatch
between patient subjective description of pain, clinician observation and “objective measures”
(Barry, et al., 2010). Reports of pain may be taken as more credible by clinicians when life
limiting illness is present. At the same time, some individuals with SUD have been known to
intentionally injure themselves (purposely contaminating wounds, causing musculoskeletal
injury, etc.) and others have been known to use conditions found on underlying radiological
imaging to “prove” they have pain (St. Marie, 2014).
For the individual with SUD, there is often isolation from the larger society, personal
relationships, health care facilities, and other resources, and their needs can be complex and
extensive (Dzul-Church, et al., 2010). Lives of those with history of SUD may be marked with
loss of relationships, homelessness, imprisonment, assault, and heavy regret, loneliness and selfreproach (Dzul-Church, et al., 2010). The relationship with a clinician in the setting of limited
social support can be a true source of comfort (Dzul-Church, et al., 2010), and the relationship
between the clinician and the individual with SUD in end of life care may represent a “last
chance” to be “known” and develop a meaningful human relationship. This is a dynamic often
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experienced in end of life care in the setting of a patient’s estrangement and isolation. However,
addressing these needs can contrast with time constraints and payer driven reimbursable
activities for the health professional (Yanni, et al., 2010).
Key Finding #4 System Barriers
System barriers impacting adequate pain assessment and management and to “knowing
the patient” were identified. Interpersonal communication, interagency, and interdisciplinary
communication were found to be barriers to effective interdisciplinary goal setting, careplanning,
and care coordination across all the stakeholders (Jablonski & Duke, 2012; Matthias, et al.,
2010;Upshur, et al., 2010). This project also identified that inadequate educational preparation
for generalist nurses, physicians and other providers about pain, addiction and end of life was a
significant barrier to effective care (Hazous & Knobf, 2013). There is also often inadequate
institutional support for developing best practices/policy/procedure around pain and EOL care
(Jablonski & Duke, 2012).
Even when institutional support and best practices have been established, there may be
inconsistent follow- up and reinforcement over time (Coker, et al, 2010). Lack of time,
excessive workload for the health care worker and inadequate financial resources of the
institutions are barriers (Coker, et al., 2010). Care of the population with pain, SUD and life
limiting illness often requires more time and resources than the ‘average” patient. Institutions
and primary care providers are not compensated by reimbursement sources for this increased
need (Barry et al, 2010).
The 0-10 numeric rating scale (NRS) for pain, nearly universally used by organizations,
was also identified as a barrier to pain assessment and management. There was a recurring
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theme within the studies of inconsistent or inappropriate use by clinicians and by patients. It was
identified that a pain tool needed to reflect more of a “common language” between clinician and
patient (Luckett, et al., 2013; Hazous & Knobf, 2013).
Limitations
Limitations of this qualitative metasynthesis, similar to other syntheses of qualitative
literature are foremost that the synthesis is reliant on the reporting and potential bias of other
authors. That being said, there is no consensus on criteria for judging the quality of qualitative
research and many legitimately argue that quality is only one of the characteristics by which to
judge the usefulness of a qualitative study. Additionally, because there is so relatively little
written specifically on the phenomenon of this project, it is not clear that the literature utilized
does indeed fully address the phenomenon. Finally, this project is limited by the possibility that
despite efforts to include all relevant studies, a key informative qualitative study may have been
overlooked.
Recommendations for Practice
Strategies for Care of the Individual with SUD and Pain at EOL
There is evidence in the literature that practice regarding pain management has often
been led by myth and bias as opposed to evidence based knowledge (Wilson, 2007). There is
evidence too that best practices are not uniformly delivered (Blayney, et al, 2012). Clinical
practice must be based on a combination of evidence, integration of individual clinical
perspective, patient preferences, and practice generated data as well as best available evidence
from research (Grinspun, et al., 2011). The literature shows time and again that pain continues to
be a treatment challenge (Khalaileh & Al Qadire, 2012), and remains one of the most common
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symptoms requiring nursing intervention - yet many are not confident in actions to be taken
(Tracy & DiNapoli, 2012). There is a need to provide the interdisciplinary team in end of life
care with an overview of the state of current evidence based literature on pain management, EOL
and SUD, as well as understanding of the gaps in evidence and areas for future research.
The combination of the key findings of this project, recommendations from the arena of
pain management and SUD, along with expert clinical knowledge and experience of end of life
interdisciplinary team members can provide a roadmap for the care of this challenging patient
population. Additionally, the findings can be operationalized into educational course content for
undergraduate nurses, physicians and other clinicians. Identification of SUD, risk stratification,
understanding and “knowing the patient”, developing a patient/family centered care plan within
an interdisciplinary team, then frequently assessing/re-evaluating and making adjustment as
necessary must be the approach to care. The clinician must recognize the unique needs of those
with pain, life limiting illness and SUD and tailor interventions accordingly. Failure to do so is a
failure to provide adequate care.
Identifying the Patient with History of SUD and Assessing Risk
The value in identifying the patient with active or history of SUD and pain at EOL is to
put solutions in place early on which support provision of compassionate, safe, effective, rational
pain management and EOL care. Gourlay, et al. (2005) were the first to recommend that pain
medicine utilize a “universal precautions” sort of approach to evaluating patients – where there is
“an appropriate minimum level of precaution” (p.107) applied to all patients. This approach for
patients with SUD and pain has been adopted by the American Society for Pain Management
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Nursing (ASPMN) as well as International Nurses Society on Addictions (INTSA) (2012),
among others.
Respectful risk assessment and risk stratification regarding potential past or present SUD
is something that should be part of assessment for all patients, including patients at end of life
(Gourlay & Heit 2009). The 10 principles of universal precautions as outlined by Gourlay, et al.
(2005) and Gourlay and Heit (2009) includes diagnosis and differential; psychological
assessment and SUD risk; informed consent; treatment agreement; pain assessment and
functional level; trial of opioid therapy ± adjuvant followed by reassessment of pain and level of
function; regular assessment of the “four ‘A’s” - Analgesia, Activity, Adverse Reactions, and
Aberrant behavior; and finally, documentation. Risk stratification is recommended as well
triaging chronic pain patients into a low, medium or high risk category (Gourlay, et al. 2005;
Gourlay & Heit, 2009). Uncontrolled substance use does not promote improved quality of life,
even in the setting of terminal cancer (Barclay, Owens & Blackhall, 2014). Barclay, et al. (2014)
recommend risk stratification of both the patient and family utilizing a validated instrument such
as the “Opioid Risk Tool”, pointing out that the patient with uncontrolled substance use disorder
and cancer have two life threatening illnesses (SUD and cancer) – and that this brings increased
suffering to both the patient and family. Additionally, the regulatory climate of pain management
must be considered, and Barclay, et al. (2014) wisely point out that clinicians must be the ones
to inform regulatory agencies about best practices for this population, rather than have practices
imposed. It is the recommendation of this author that these structures be adapted for use in the
hospice setting.
Harm Reduction
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“Harm reduction” is a patient centered strategy in the care/treatment of those with SUD
and can be defined as a “public health approach to dealing with drug related issues that places
first priority on reducing the negative consequences of drug use rather than on eliminating drug
use or ensuring abstinence” (Riley et al.1999, as stated in Lee & Zerai, 2010, p.2412). “Success”
can be said to include demarginalization, development of a mutually trusting relationship,
engagement, improved quality of life and social functioning, changes in substance use,
formulation of goals and plans, and any perceived positive change (Lee & Zerai, 2010). Most of
these elements of harm reduction overlap the elements of “knowing the patient” as found in this
project and are in harmony with one another.
Additionally, two of the qualitative studies utilized in this project by McNeil and
Guirguis-Younger (2012), as well as McNeil, et al. (2014), demonstrated specifically the
effectiveness in the integration of harm reduction strategies to improve access to and engagement
with palliative and other support care services for patients living with HIV and SUD. So,
extrapolating those findings, it is clear that it would be efficacious for the clinician/prescriber
and interdisciplinary team to utilize harm reduction strategies to frame the end of life care and
pain management interventions of a patient with SUD. In the hospice setting, we meet
individuals “where they are” - and mindfulness about harm reduction strategies would be a “fit”.
Dissemination and Implementation
Evaluating and understanding barriers to change implementation in the clinical setting is
essential in order to achieve optimal patient outcomes (Gifford, et al, 2013). Access to research
results is a known barrier to evidence based practice in nursing and medicine (Kehl & McCarty,
2011). While evidence based clinical practice guidelines are the gold standard for care, some
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estimates indicate as many as 30-45% of patients do not receive this level of care and 20-25% of
interventions may even be unnecessary or harmful (Gifford, et al, 2013). Gifford, et al.’s 2013
study categorized a number of generalizeable barriers to change implementation and recommend
that leadership develop intervention strategies linked to the different barrier levels:
•

Individual barriers – relating to a provider’s knowledge, skills, attitudes and beliefs.

•

Team level barriers – relating to interactions between the team members –
communication problems, unclear expectations and unclear social norms

•

Organizational level barriers – relating to the practice environment – structures,
equipment, policies and procedures

•

System level barriers – relating to policy makers, workloads, staffing,

•

Patient level barriers – relating to patient resistance to change, or communication
challenges with other health care services/community partners.
Eventhough there may be interest in, and resonance with the subject matter of this project

by clinicians, there may be challenges with implementing any practice change on individual,
systems, organizational, and patient level. Many organizations are under considerable duress just
to provide adequate day to day operations, often running very lean in terms of staffing.
Additionally, education on subjects relating to regulatory issues and compliance, usually take
precedence over items of interest for clinical practice. Provision of education, mentoring, role
modeling, clarifying roles and expectations, being sensitive to organization priorities, ensuring
cooperation of key organizational personnel, being flexible and sensitive to time (and time as
money), and clarifying communication channels are all critical to successful dissemination of
information and practice change (Gifford, et al, 2013).
Personal Practice Change
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You matter because you are you; you matter to the last moment of your life and we will
do all we can to help you not only to die peacefully but also to live until you die
(Saunders, 1976)
To summarize what I, as a DNP, am incorporating into my personal practice and will take
back to my EOL practice sites and professional organizations:


Practice/procedure change to make early identification of those with SUD part of routine
provider/prescriber, nursing and psych/social assessment



SUD Risk stratification



Reinforcement of the subjectivity of the patient’s report of pain



Acceptance of the patient’s report of pain



Implementation of harm reduction strategies



Interdisciplinary team care plans reflecting risk stratification and harm reduction
interventions to support the patient and family in goals of care.



Nothing can take the place of truly “knowing the patient” –time, creative staffing and
other resources must be put in place to accomplish this.
Assuring that individuals have a “good death” and good quality of life up until that time

is a priority of quality end of life care. As previously pointed out, pain is often under or
untreated and patients with co-occurrence of SUD at end of life are a vulnerable group known to
be at even higher risk for undertreatment of pain. A place to begin the findings dissemination
and implementation process is to engage Quality Assurance Performance Improvement (QAPI)
committees within organizations and utilize that structure to review the research findings,
strategize to adopt the findings, create a format for piloting and implementing practice change,
and then further disseminate results to the larger health care community.
Recommendations for Continued Research
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This project underscores the need for further research on the phenomenon of pain
management at end of life when there is a co-occurrence of SUD, and development of strategies
to effectively provide excellent end of life care to this population. However, this project has
brought other gaps to light as well. Of particular significance are the problems raised with the
widely used 0-10 Numeric Rating Scale (NRS). Within the findings of a number of the studies
utilized in this qualitative metasynthesis, all participants – patients, nurses, provider/prescribers
and family members identify the NRS scale as incomplete and difficult to use effectively
(Upshur, et al., 2010; Esquibel & Borkan, 2014; Luckett, et al., 2013; Hazous & Knobf, 2013;
Coker, et al., 2010; Barry, et al., 2010 to name a few…). So, there is a need for further research,
development and universal dissemination of improved, valid tools of pain assessment,
particularly in the setting of end of life and SUD. Based on the findings of this project, pain
assessment tools must take into account the meaning of pain in the context of function and
quality of life (Esquibel & Borkan, 2014). They must be culturally sensitive and individually
defined, and may be more effective if “storytelling” is incorporated (Hazous & Knobf, 2013).
There must be a common language when describing pain (Simone, et al., 2012), and the pain
assessment tools and communication must be meaningful (Coker, et al., 2010). While
identification of patient goals and goals of pain management are seen as important, they are not
often identified (Bhatia, et al., 2014).
The concept of “knowing the patient” as a basic practice model has been recognized in
the literature for well over 20 years, but has had little prominence in recent years, as many
current practice environments do not create a setting conducive to this. Continuity of care,
frequent patient contact, and development of positive relationships are central to knowing the
patient but may not be supported, especially in the acute care setting (Zolnierek, 2014). That
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being said, one can argue that “knowing the patient” is at the core of expert care and practice.
Serendipitously, “knowing the patient” was identified as the overarching theme for the effective
care of patients with pain and SUD at EOL in this qualitative metasynthesis. Further research
on “knowing the patient”, as both a clinically effective and cost effective approach to care must
be undertaken.
Harm reduction strategies are recognized as important patient centered programs which
improve quality of life, social functioning, adherence, access and marginalization of the SUD
population (Lee & Zerai, 2010). There must be further research on these strategies to improve
EOL care and pain management in this population.
Gourlay and Heit (2009) and Barclay et al. (2014) among others advocate use of SUD
risk stratification – this could be a useful strategy in planning care of patients at end of life, but
current screening tools are not specifically for use in EOL care. Further research is needed to
develop and implement SUD risk screening tools for use at end of life.
Conclusion
The purpose of this project was to evaluate the qualitative research literature on the
subject of pain at EOL when there is a co-occurrence of SUD, interpret the evidence, and make
recommendations for practice. The project was framed by Margo McCaffery’s pain definition
and concepts. McCaffery’s definition of pain remains a simple truth, as it was when first
introduced. Pain can only be a subjective experience, and there is no more reliable gauge of pain
than the individual’s subjective report. The findings of this metasynthesis again confirm this.
However, the findings also confirm that clinicians continue to struggle with this subjectivity.
The concept of whether or not a patient is in “genuine” pain is prevalent among clinicians
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(Baldacchino, Gilchrest, Fleming, & Bannister, 2010). It is far easier for individuals to accept a
patient’s report of pain if there is something objective to “see”: a diagnostic, a fungating tumor,
a disfiguring head/neck cancer, etc. Additionally, the literature reviewed and utilized in this
project repeatedly reported that despite advances in the science of pain management and the
availability of interventions, pain is often undertreated in general as well as at end of life.
For the clinician, there is clear ethical direction for the optimal treatment of pain, and
failure to do so constitutes malpractice, in that the ethical principles of beneficence and nonmaleficience mandate pain relief - as pain causes harm and the relief of pain is beneficial (Head,
2011). Additionally, beginning in January of 2015, as part of CMS’ Hospice Quality Reporting
Program (HQRP) ( the hospice quality reporting measures mandated by the 2010 Affordable
Care Act), appropriate assessment and treatment of pain is one of the “official” end of life
quality measures. So while this all provides seemingly clear direction for clinicians, at the same
time there remains “rigid and often punitive federal control over opioid analgesics” (Rich, 2009
as stated by Head, 2011 p. 58), the drugs which are the current mainstay of end of life pain
management.
As part of a comprehensive patient assessment, nurses, nurse practitioners, physicians
and other clinicians are taught to take what the patient says, combine it with what we see, hear,
smell, feel, and form an assessment, and from there develop a plan of care with interventions and
evaluation. We are further taught to take note of discordant and conflicting data. So it is really
not surprising that clinicians have difficulty looking past their own subjective (albeit “objective”)
experience of the patient’s pain report. Additionally, the findings of this project clearly identify
fear of judgment, litigation, addiction, and diversion as motivators of behavior for the clinician
in terms of pain assessment, management, and prescribing practices. This, combined with
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contradictory messages all around, lead to pain being inconsistently and suboptimally assessed
and managed in all populations, not the least of which being the population with a history of
SUD.
However, echoing McCaffery’s basic concepts, the clinician must accept the patient’s
report of pain – this is indisputable, but this is not meant to be the stand alone answer to the
conundrum. This begins the process that clinicians may find difficult, contradictory, time
consuming, and frustrating, but this is the starting point from which pain management can begin.
The findings of this project identify the population with history of SUD as a vulnerable
population at risk for being undertreated for pain at end of life. The key finding of “mutually
exclusive rituals” sheds light on some of the characteristics of the individual with SUD, which
make pain management in this population unusually challenging, and emphasizes the knowledge
deficits regarding pain management that exist for the generalist clinician, especially with regard
to SUD. As sub themes of the key finding “knowing the patient” , components of good qol for
individuals with pain (with or without life limiting illness, and with or without SUD) were
identified along with barriers to good qol for individuals with SUD and pain (with or without
life limiting illness). These findings, together with the identified “fears” from the perspective of
the patient, provide greater depth and texture to the picture of the patient with SUD, pain, and
life limiting illness, and provide some practice guidance for the clinician.
System barriers to effective pain management were identified in this project as well. Our
regulatory and licensing bodies, educational systems, insurance/payer sources, and institution
policies & procedures, must be in alignment and in communication with each other for the
comprehensive identification and care management of the patient with pain and SUD at EOL.
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The clinician must believe reports of pain, but must also invest the time, appreciate patient
motives, strengths and challenges, facilitate the clarification of mutual and individual goals and
expectations , and incorporate an interdisciplinary approach to pain management . Clinicians
must become “culturally competent” in the care of this population – there is no shortcut to the
solution, and truly knowing the patient is the foundation.
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Appendix A

Taxonomy of Findings
I.

Patient Perspective

A. End of Life and Illicit Drug Users
“I need a doctor to come see me…a nurse or whatever. I’m getting too weak to take care of
mysef. It’s coming…the end. I can tell… It’s getting to where I’m not going to be able to do
anything…help me once, twice a week. Just help me brush my hair… make me look pretty
again…(Church, et al., 2010).”
1. Lives filled with loss – relationships, homelessness, addiction, imprisonment, assault
(Dzul-Church et al, 2010)
a. Isolation
b. Mistrust
2. Lives filled with regret (Dzul-Church et al, 2010)
a. Emotional/Spiritual Pain
3. Relationships with health care providers as a source of support (Dzul-Church et al, 2010)
a. Another chance to develop a meaningful relationship
4. Previous experiences with death were often sudden and violent/concern for how their
bodies would be treated after death (Dzul-Church et al, 2010)
a. Mistrust
b. Fear
5. A life of coping with challenges – experiences of self advocacy, reliance on religion and
spirituality (Dzul-Church et al, 2010)
a. Resilience
b. Hope
c. Survival mode existence
6. Underserved patients at end of life require greater understanding of the ways that their
difficult life stories influence their experiences (Dzul-Church et al, 2010)
a. Healthcare providers must see the Humanness and know the story
7. Wish for improved relationships with health care providers and greater access to
chaplaincy and other services (Dzul-Church et al, 2010)
a. Potential for improved outcomes with improved healthcare system design
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B. Chronic Non-Cancer Pain (CNCP)
“…find out about the person. What did you do? Where do you see life going? You got
kids?...the only way you’re really gonna understand me and keep your eye on me is I want you
to know me a bit – to make sure I’m not fooling you… (Upshur, et al., 2010)”
1. Ability/Inability to accurately describe pain (Upshur, et al, 2010)
a. Inadequacy of current pain scales
2. Pain takes away ability to function (Esquibel & Borkan, 2014), Strategies to cope with
pain (Upshur, et al, 2010)
a. Survival mode
3. Pain relief is a high priority (Esquibel & Borkan, 2014)…Many patients with CNCP
benefit from high doses of opioids long term…Pain is often nerve pain (Watson, 2012)
4. Pain leads to more suffering and depression (Esquibel & Borkan, 2014)
a. Downward spiral
5. Potential for abuse and diversion exists, but must not deny access to pain relief (Watson,
2012)
a. Trust vs. Mistrust
b. Doing the greater good
c. Importance of Education
d. Harm reduction
6. POSITIVE Perception of Physician (Prescriber) as advocate/friend – beneficial
relationship when pain is validated, patient centered, shared decision making (Esquibel &
Borkan, 2014) Importance of shared decision-making, empathy, trust, understanding of
pain level, clear communication; importance of a “compassionate partnership”, evidence
based guidelines, use of technology, direct phone or email contact and format for quality
improvement (Upshur, et al, 2010)…Trust is essential
a. Importance of truly knowing the patient
b. Importance of accessibility
c. Importance of “partnership”
d. Importance of “patient centered medical home”
7. NEGATIVE Perception of Physician (Prescriber) as “sheriff”, poor listener, distrustful …
conflictual when physician centered and directed, when pain is not validated, when pt is
perceived as drug seeker (Esquibel & Borkan, 2014)
a. Lack of education, limited guidelines
b. Lack of time
c. Inadequate assessment tools
d. Lack of empathy
C. Opiate Dependency, Prescription Opioid Abuse (POA), Drug Abuse, with and without
Pain
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“I took the pills like he (the doctor) told me to at first. And everything was fine, but I fell in
love with the buzz. It makes you feel like a million bucks. It really does. Don’t get me wrong,
it took away the pain in my jaw, but the best part was that it took away your other pains too
(Rigg & Murphy, 2013).”
1. For opiate dependent individuals in methadone maintenance, contributions to good QOL
include having social relationships, an occupation, good self image, being independent
and having a meaningful life (DeMaeyer, et al, 2011) On the other hand, strong
ambivalence exists – concern for withdrawal, limitations caused by opiate (now
methadone) dependency including isolation, psychological problems, anxiety,
discrimination.
a. Desire for Normalcy
b. Need for De-stigmatization
2. Harm Reduction and Abstinence as part of a continuum; aim by some for an opiate and
methadone free life, while abstinence for some may not be realistic or desirable
(DeMaeyer, et al, 2011)
a. Must have patient centered, individually tailored approach to care
b. Need for education
3. Contrasting perceptions and expectations by nurses and drug users of the therapeutic
relationship – expectations by drug users that health care workers be non-judgmental and
show compassion (McCreaddie, et al, 2010)
4. Drug use explained by the user as a side effect of other negative life events (McCreaddie,
et al, 2010)…Need to give meaning to actions – especially hidden behaviors such as
substance abuse (Rigg & Murphy, 2013)…
5. Long standing hardship in childhood or adolescence leading to a “defining moment” that
turned the individual down a path of substance abuse and addiction (Rigg & Murphy,
2013).
6. Benefit in understanding which comes first – substance abuse or pain (St Marie, 2014).
7. Negative experiences: include feeling disbelieved, feeling stigmatized, health providers
not providing care (St Marie, 2013). Positive experiences include success in sobriety,
trust and confidence in the health care provider (St Marie, 2013).
a. Importance of looking at risk stratification
b. Importance of KNOWING THE PATIENT
c. Medicating non-pain symptoms with pain medication
d. Drugs at least initially “feel good”
e. Importance of supporting individuals when they are at a “defining moment”
8. A drug users routines and rituals must be followed in order to prevent withdrawal and
manage pain… these rituals may be “illegal & chaotic” (McCreaddie, et al, 2010).
a. Mutually exclusive rituals
9. Coexisting pain and substance use disorder can activate and potentiate the other, and drug
craving may drive patients to deception (St Marie, 2013).

Running Head: PAIN MANAGEMENT AT END OF LIFE

55

a. “Reasons” for mistrust, self preservation or at least caution
10. Prescription opioids more desirable as an abusable agent as they are perceived as safer,
purer, longer lasting and stronger (Rigg & Murphy, 2013)
11. Older drug “abusers” needs may be different than those of younger substance abusers.
They are at increased risk of morbidity, loneliness, stress, and anxiety (Roe, et al, 2010).
12. Drug use has a negative impact on health, qol, family relationships and social networks.
Loss of key relationships… Encounters with death and dying are common and
experienced at an earlier age for this group (Roe, et al, 2010)
13. Some see their own survival as resilience (Roe, et al, 2010).
a. Regret
b. Recognition of accelerated aging and health changes
c. Struggle with survival, death and dying
d. Importance of knowing the patient/knowing their story/individual needs
e. Importance of connecting with a patient’s inner resilience
D. Cancer Pain
“I don’t want to take too many pain killers. If I would always take pills as soon as it hurts
a bit, I’d need a much higher dose in a few weeks. I am not going to do that… (Knudsen,
et al., 2012)”
“I was really wondering about what caused the pain. What I feared most was probably
that the cause was metastases…(Knudsen, et al., 2012)”
“Elders are hesitant to take narcotics. They aren’t up front about it, but they won’t take
them. The older folks would rather suffer with the pain than feel they were out of touch
with the earth/world. They don’t like th hazy feeling (Hazous & Knobf, 2013).”
“I was sitting in the office and thinking, ‘Oh dear God, please don’t let it be someone
where I have to sit and explain myself to him and start all over’(Luckett, et al, 2013).”
1. Cancer pain impacts all areas of life (Luckett, et al., 2013)
2. Cancer pain and treatment exist in a cultural and social context (Luckett, et al., 2013)
3. Patients are experts in their own pain management, (Luckett, et al., 2013)
a. Need for patient centeredness
4. Perceived lack of support by health professionals for non pharmacological and
complementary and alternative pain management strategies (Luckett, et al., 2013)
a. Failure to identify patient goals
5. Opioids and opioid concern/opioids as a balancing act… concern that commencement of
opioids represents worsening disease and death… a conflict for patients with increasing
pain (Flemming, 2010).
6. Breakthrough pain in cancer as a unique phenomenon – acceptance that analgesics
improve quality of life, but internal conflicts regarding opioids use and potential side
effects – including masking the pain and fear of addiction (Weber, et al., 2011).
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a. Fear of the unknown
b. Pain as anxiety
c. Being a victim vs. being empowered
d. Recognizing the subjectivity of the experience
7. Pain management barriers: desire for privacy, fatalism, isolation, knowledge deficits,
family as both helping and hindering (Hazous & Knobf, 2013),
a. Importance of sensitive and culturally competent assessment and care of pain
b. Pain and pain management as culturally and individually defined
8. Anxiety over addiction (Flemming, 2010)
9. Use of and dependence on strong analgesics worrisome but at the same time concept of
addiction less important to the patient in severe pain (Knudsen, et al., 2012).
10. Repeated instruction by health care workers regarding dependency and tolerance
decreased patient concerns (Knudsen, et al., 2012).
11. Challenges coping with the side effects of pharmacological pain management
(McPhearson, et al., 2014).
a. Importance of education
b. Importance of supporting function and self efficacy
12. Patients develop physical, practical and psychological strategies for coping with pain
(Knudsen, et al., 2012); Cultural norms defining expression and treatment of both pain
and cancer (Luckett, et al., 2013)
a. Must know the patient in order to support coping styles
13. Living with pain affects all aspects of life…Communicating and then finding a solution
to pain (McPherson, et al., 2014).
14. Tradeoff between analgesia and the side effects of opiates becoming acceptable when
pain is intolerable and death is perceived as imminent (Flemming, 2010).
a. Importance of goal setting and clarifying mutual expectations
15. Pain scales being difficult to use…Pain better described by storytelling (Hazous &
Knobf, 2013)
a. Importance of culturally appropriate pain scales/tools
b. Giving patients “permission” and education to use pain relief tools
16. Emotional Pain, family demands and stigma associated with opioid use (Hazous &
Knobf, 2013) Anger, frustration, sadness and despair, powerlessness, helplessness and
loss of control (Knudsen, et al., 2012). Not wanting to use prescribed pain meds – desire
for privacy, knowledge deficits, fatalism (Hazous & Knobf, 2013).
a. Must anticipate needs/situations
b. Must be transparent in communication
17. Spiritual Pain, belief in causality, inability to participate in community and spiritual
activities (Hazous & Knobf, 2013)
a. Respect for cultural/spiritual practices
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18. Other consequences of pain include domains of duration, intensity, coping, physical and
psychological function, as well as quality of sleep, (Knudsen, et al., 2012)
a. Duration and persistence of pain as draining
19. For most, previous experiences with pain are not relevant to the experience with cancer
pain (Knudsen, et al., 2012)
a. Pain has different weight and meaning when attached to mortality
20. Severe pain as impairing cognitive function and concentration (Knudsen, et al, 2012)
a. Identifying goals of care and pain relief
b. Importance of self efficacy/control
21. Revealing and concealing pain to protect a caregiver or loved one, believing in
pharmacological pain control as well as non pharmacological approaches, importance of
knowing in order to identify pain (McPhearson, et al., 2014)
22. Pain is perceived as a significant problem for patients with cancer but inadequate pain
management is common, with barriers of provider education and endorsement, cost and
concerns about addiction – eventhough malignant pain is most often greatly improved
with medical management (Simone, et al., 2012).
a. Trying to be a “good patient”
b. Importance of accurately assessing pain/knowing the patient – must be proactive,
not reactive or passive
c. Education to be able to support both pharmacological and non pharmacological
approaches and to facilitate teaching.
d. Openness and mutual transparency/honesty
e. Importance of a “common language” in describing pain – ongoing difficulty with
pain scales.
23. May have sub optimal pain management until patient is referred to palliative or pain
specialists (Weber, et al., 2011)
a. Education/knowing resources/team approach
b. Importance of expert knowledge
24. Need for “therapeutic alliance” between patient, family cg and health professionals and
shared power and responsibility (Luckett, et al., 2013)
a. Pt/family centered approach
b. Interdisciplinary approach

II.

A.

Nursing Perspective

End of Life and Illicit Drug Users
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“We kind of got caught off guard because our first client that got sick was quite young and
experienced profound liver failure, extremely fast. He had to go to the hospital. He didn’t
want to but he had to. We didn’t have any nursing support in place. We didn’t have
equipment. We didn’thave the drugs. He had to go to the hospital to die. It set us into our
planning stage for the next event – getting equipment, nurses, drugs, aand all these things in
place for the next person - Nurse Manager (McNeil et al., 2012).”
1. Nurses identify that barriers to end of life care services in this population include
healthcare as a low priority, the mistrust of healthcare providers, “system” zero
tolerance of illicit substances (McNeil & Guirguis-Younger, 2011)
a. Need to know the patient/the story
2. Nursing intervention impacted by non- disclosure of drug use, concern for high levels
of tolerance to palliate symptoms, challenges of care interruptions, and Nurse
knowledge deficits about addiction and care of this population (McNeil & GuirguisYounger, 2011).
a. Need for flexibility and seeing the greater good
3. Not realistic for this population to abstain from illicit drug use at end of life, thus
harm reduction as approach to care for this population (McNeil & Guirguis-Younger,
2011).
a. End of life care when there is addiction requires special knowledge and
approaches to care
b. Goals of care must be individualized
4. Harm reduction supports improved access to palliative and support services (McNeil,
et al., 2014). Harm reduction promotes openness in communication and improved
health outcomes (McNeil, et al., 2014).
a. Knowing the patient/culture/currency
b. Poor educational preparation of the generalist to address these challenges
effectively
c. Being open to harm reduction strategies
B. Chronic Non-Cancer Pain (CNCP)
“Disorganized system of care: e.g., having to hunt for narcotic keys, obtain co-signatures, find
drugs, etc…Not knowing whether to believe the older patint’s pain report or the family’s
perception of the person’s pain instead…(Coker, et al., 2010)”
1. Patient related barriers: cognitive impairment, language barriers, sensory problems, pain
reported to MD but not nurse, problems with using pain scales, willingness to bear pain,
not wanting meds due to side effects (Coker, et al., 2010)
a. Need for nurse to really know the patient
b. Must promote change to overcome system and knowledge deficits
c. Pain scales must be meaningful
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2. Systems barriers: inadequate time for patient teaching, inadequate time for non
pharmacologic pain relief, non pharmacological pain measures not available,
disorganized care system (Coker, et al., 2010)
a. The discrepancy between the nurse “knowing” and the nurse “doing”
b. Making time for optimal care
c. Need for continual organizational support and reinforcement of “best practices”
with regard to pain assessment and management
3. Fear of over medicating (Coker, et al., 2010)
a. Knowledge deficits
C. Opiate Dependency, Prescription Opioid Abuse (POA), Drug Abuse, with and without
Pain
“I think some of the nursing staff think ‘well why am I bothering? I’m trying my best here
and you’re doing something like that’ – or you’ve got the guy who broke his ankle and walked
on it straight away. You know he was walking on it, but he would not listen…(Mcreaddie, et
al, 2010)”
1. Connecting with drug users “as people not problems” (McCreaddie, et al, 2010)
a. Knowing the patient
2. Contrasting expectations and perceptions of the therapeutic relationship…struggle with
moral relativism (McCreaddie, et al., 2010)
3. Generalist nurses may have stereotypical ideas of patients with opiate dependency
DeMaeyer, et al., 2011)
a. Knowledge deficits regarding pain, addiction, dependency
4. Nurses must demonstrate psychosocial support and positive interactions – but may
perceive drug users as immoral, responsible for their health outcomes (DeMaeyer, et al.,
2011)
a. Education to counter deep seated personal biases
b. Knowing but not doing
5. The routines and rituals of nursing as organized and efficient, authoritative and in control
may be at odds with the rituals and routines of drug users (DeMaeyer, et al., 2011).
a. Potential for mutually exclusive rituals and routines for nurses and drug users
6. Nurses must have system support to develop professional skills and attitudes and create a
positive environment to care for this population (DeMaeyer, et al., 2011)
a. What does effective care of this population look like?
b. Harm Reduction approach
c. Need for mentoring and leadership that model effective care of this population
d. Knowledge deficits regarding pain, addiction, dependency
D. Cancer Pain Management
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“If the doctor would just listen to my opinion…it’s frustrating if the patient is in pain and the
doctor is not willing to prescribe the medication…(Luckett ,et al., 2013).”
“I perceive my role as primarily to educate, and then to empower, and then to act as an
advocate (Luckett, et al., 2013).”
“You definitely have to have teamwork up here. If you don’t have teamwork, nothing will go
on (Luckett, et al., 2013).”
1. Nurses play major role in cancer pain management (Flemming, 2010)
2. Nurses feel relieved when patient pain is relieved (Flemming, 2010)
a. Pain management is different when there is grave illness
3. Expectation by patients that nurse be a caring individual (Luckett, et al., 2013)
4. Hierarchy of the medical system and rigid roles have negative impact on teamwork and
pain management– nurses feeling that they are not always heard – yet most all place a
value on teamwork – but operationalization is needed (Luckett, et al., 2013)
a. Need for patient centered, collegial/team approach
b. Knowing but not doing
5. Encounters with patients’ Existential Pain – leading to feelings of powerlessness,
insufficiency and uncertainty when facing death and dying vs. development of open and
close therapeutic relationship with patient and family (Browall, et al., 2014)
a. Having the courage to be truly present
6. The value of listening to patient stories, helping patients summarize and reflect about
their lives, and through this, gaining insight into patients ‘existential needs (Browall, et
al., 2014)
a. Having the courage and taking the time to know the patient, while remaining
therapeutic
b. End of life care must be comprehensive with an interdisciplinary team
7. Balancing honesty with not telling the “whole truth” (Browall, et al., 2014)
a. Preserving hope
8. Feeling responsible for assessing that home environment is safe from substance abuse or
diversion (Flemming, 2010)
a. Mistrust
b. Gatekeeper role
E. End of Life and Pain
“…sometimes it does not seem like the physician is listening to what I am saying… I am the
one closest to the patient…and assessing them all day…(Jablonski & Duke, 2012).”
“…Families will not ask patients if they are hurting… because they don’t want the patient
sedated where they will not be able to interact with them…family members want their loved
ones to be comfortable, but not always to the point of unresponsive… want to spend the last
days…hoping that the patient can respond right up until death…(Jablonski & Duke, 2012).”
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“Nursing Home nurses are health care professionals but many are scared of giving morphine
and causing a patient’s demise…or afraid to ‘get the patient addicted’, or that they will make
the patient ‘all drugged up’…for some, they don’t want morphine in their home because they
have family members with substance abuse problems (Lau, et al., 2010).”
1. Barriers to effective pain management include limited knowledge, skills & experience,
judgmentalism, conflicts, time waiting for orders, authoritative boundaries, and fears of
addiction and accidental overdose, fear of litigation (Jablonski & Duke, 2012).
a. Need for patient centered care
2. Facilitators of effective pain management include education, individualized care and use
of specialty services (Jablonski & Duke, 2012)
a. Goal setting
b. communication
3. Despite awareness, inadequate pain management persists and there has been little in the
way of incorporating knowledge, attitudes and practice (Jablonski & Duke, 2012).
a. Discrepancies between “knowing” and “doing”
4. Effective communication between physicians, nurses patients and families is critical
(Jablonski & Duke, 2012) must establish trust, provide information, promote self
confidence, offer relief and evaluate understanding (Lau, et al., 2012)
a. Importance of interdisciplinary care
b. Importance of coordinating with all the stakeholders
III Provider/Prescriber/Physician Perspective

A. Chronic Non Cancer Pain (CNCP)
“…because if you’ve dealt with any of these patients, then you’ll know they’re the
most irritant substance on the planet from any others…I would hope that I would give
them the best medical care I could, but I’m not prepared to sit and be manipulated by
them – Pain Specialist – (Baldacchino, et al, 2010).”
“...they take up an inordinate amount of time…trying to address what the pain is and the
causes for it takes up an inordinate amount of time…this is why you have to limit the number,
you cant carry a lot of them because there’s so much paperwork…(Barry, et al, 2010).”
1. Opioids have a useful place for some patients with CNCP (Baldacchino, et al., 2010) but
chronic opioids use is not preferred modality (Esquibel & Borkan, 2014) not first line
treatment (Spitz, et al., 2011)
2. Harm of using opioids outweighs potential benefits for CNCP (Spitz, et al., 2011)
3. Treatment of chronic pain as frustrating (Spitz, et al., 2011)
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4. “Opiophobia” present for many General Practitioners (Baldacchino, et al., 2010), a
“confounding concern” for first year medical students (Corrigan, et al., 2011) vs. feeling
pressure to prescribe opiates (Matthias, et al., 2010)
5. Not wanting to prescribe opiates to people with known history of substance use
disorder/not wanting to “feed the habit” (Baldacchino, et al., 2010)
6. Looking for drug seeking behaviors e.g. lost prescriptions, early medication request,
prescriber/pharmacy shopping (Baldacchino, et al., 2010)
7. Awareness of patient reluctance to reveal drug use (Baldacchino, et al., 2010)
8. Absence of objective measures of pain (Barry, et al., 2010) Difficult to accept and treat
nonobjective pain (Esquibel & Borkan, 2014)
a. Frustration
b. Ineffective pain assessment tools and guidelines
9. Lack of awareness/interest/expertise in treating CNCP or prescribing opiates and the
combined co-occurrence of psychiatric disorders and addiction (Barry, et al., 2010), lack
of willingness to utilize harm reduction interventions (Butler & Sheridan, 2010) lack of
confidence in treating pain (Esquibel & Borkan, 2014)
a. Knowledge deficits
10. Treating pain may not be seen as top health priority (Esquibel & Borkan, 2014)
11. Limited referral options, limited insurance coverage, limited knowledge about the patient,
limited time (Barry, et al., 2010)
12. No unified picture of a “typical” drug seeker – but two main typologies: the “abuser” and
the “overuser”(Butler & Sheridan, 2010)
13. Aberrant drug use seen as a covert activity (Butler & Sheridan, 2010)
a. Mutual mistrust
14. Pain as a biopsychosocial model (Esquibel & Borkan, 2014)
a. Objectivity vs subjectivity
15. Facilitators include patient & family education, using risk assessment tools, finding peer
support, education regarding dosing (Spitz, et al., 2011).
16. Ongoing education in pain management and specialty roles should be mandatory
regardless of specialty, residents felt unprepared to treat CNCP (Yanni, et al., 2010).
17. Shared findings of other studies that providers often underestimate pain (Yanni, et al.,
2010)
18. Excessive time needed for patients with chronic pain who often have co-morbid
psychiatric conditions (Yanni, et al., 2010)
a. The system does not support appropriate reimbursement for the care and
monitoring of the CNCP population
b. Compassion fatigue and burn out
19. Conversation may be the best pain assessment tool, patient centered communication,
empathy and shared decision making (Matthias, et al., 2010). Opioid agreements – one
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prescriber, no change in dosing, no early refills, random drug testing (Schneider &
Kirsch, 2010).
a. Knowing the patient
b. Need for education
c. Mutual trust
B. Cancer Pain Management
“We are bombarded by guidelines which are not based on evidence and the local hospitals do
it and send them out to us. It just creates confusion…(Luckett, et al., 2013).”
“I’ve seen cancer patients for years that should never have been in the pain they were in and
people were afraid they were going to get addicted or die so they didn’t treat them
appropriately…(Luckett, et al., 2013).”
“If you can’t find that pathophysiologic connection, the question then becomes, ‘is the pain
real or not?’ (Luckett, et al., 2013).”
1. Pain relief perceived as equating to improved mood and function (Bhatia, et al, 2014)
2. Pain relief perceived as fewer breakthrough doses needed (Bhatia, et al., 2014)
3. While pt goals and goals of pain management are seen as important, they were not often
identified (Bhatia, et al., 2014).
a. Knowing but not doing
b. Not really knowing the patient
4. Difficulty judging treatment response by pain scales (Bhatia, et al., 2014); preference of
using objective and subjective pain indicators… desire to verify that pain is as severe as
reported (Luckett, et al., 2013).
a. Ineffectiveness of standard pain scales
5. Dissatisfaction with existing clinical guidelines (Luckett, et al., 2013)
6. Existential meaning of cancer & cancer pain – pain is about the patient (Flemming, 2010)
7. Intersubjectivity of pain (Flemming, 2010)
8. Teamwork required to successfully treat pain (Flemming, 2010).
9. Fears around addiction explicitly or implicitly communicated to patients (Flemming,
2010)
10. Fears around diversion (Flemming, 2010)
11. Time limitations and workload leading to rushed encounters (Luckett, et al., 2013)
12. Taking the success or failure of pain management strategies personally (Luckett, et al.,
2013)
C. End of Life and Pain
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“I realized that it’s OK to listen to the patient when they say they are hurting. I also
learned the importance of validating the feelings of someone who is suffering
(Corrigan, et al, 2010).”
“Being on opiates might mean that the patient is near death, that I am giving up on
them, or that they themselves are giving up (Zerzan, et al.,, 2010.”
“Listening to patients talk about their pain and suffering all day is exhausting. It is so
draining to listen and be empathetic…and then you get patients with whom you don’t
want to be empathetic. You don’t ike them that much and you still have to ccare and
you still have to listen…I don’t know that I want to care that much (Corrigan, et al,
2010).”
Pain as a concern to first year medical students (Corrigan, et al., 2011)
Encounters with acute, chronic, end of life, iatrogenic and emotional pain were mostly
negative for first year medical students in primary care setting (Corrigan, et al., 2011)
a. Medical education must include tools to address pain no matter what the specialty
Multidisciplinary team as essential to facilitating opioid prescribing and providing
effective EOL care (Gardiner, et al., 2012).
Health professionals in primary care lack confidence in prescribing opioids (Gardiner, et
al., 2012).
Improved guidelines for EOL opioid prescribing are needed for the general practitioner
(Gardiner, et al., 2012)
Social meaning of opiates and personal experiences with opiates, whether or not patient
has history of substance abuse and diagnosis drive prescribing (Zerzan, et al., 2011)
Barriers include restrictive policies, institutional barriers, concerns for addiction or
misuse, fear of the DEA , history of disciplinary action (Zerzan, et al., 2011)
EOL opiates may hold a different social meaning to the prescriber, the patient and the
family (Zerzan, et al., 2011)

III Caregiver Perspective
A. Cancer Pain Management
“The hardest part is watching the mind go and the body waste. Bone cancer is so painful, will
my mother go into a coma? Will the pain be controlled as we have been promised? (Luckett, et
al., 2013).”
“They should really treat you as someone other than the person who drove the car (Luckett, et
al, 2013).”
“It’s not a sense of duty. I don’t think that would be the right way to put it. It’s just something
that seems to be filling something inside of me (Luckett, et al., 2013).”
1. Family as helping and hindering pain management (Hazous & Knobf, 2013). Conflict
between supporting patient choices and doing what’s “best” (Luckett, et al., 2013)
2. Potential for family caregivers to feel marginalized, but at the same time they play an
important role in monitoring and management of pain and pain interventions (Luckett, et
al., 2013).
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3. Communicating pain and finding a solution – changing roles as patient declines
(McPherson, et al., 2014)
4. The caregiver can be seen as both the recipient and co-provider of care (Meeker, et al.,
2011)
5. Caregivers are more likely to use pharmacological approaches to pain, while non
pharmacological approaches are patient preference (McPherson, et al., 2014)
6. Successful pain management must include the family caregiver – and accuracy of
caregiver knowledge was associated with lower pain in the patient (Meeker, et al., 2011)
B. EOL Pain Management
“….she has chronic pain…the morphine was in an unusual bottle and I was afraid to giver
her too much or too little and the dropper wasn’t working. It was very scary…(Kelley, et al.,
2013).”
1. Concurrent responsibilities- work outside the home, caring for other ill family members,
financial burden (Kelley, et al., 2013)
2. Fears of over/under medicating patient (Kelley, et al., 2013)
3. Knowledge deficits regarding EOL symptom management (Kelley, et al., 2013)
a. Nothing substitutes for really knowing the patient and family
b. Anticipating and educating about disease progression and symptom management
c. Need to individualize pain and symptom management and to titrate to effect
4. Caregiver “owning the setting”, mistrust of interventions and perceiving that they know
what’s best, differences in priorities and abilities (Lau, et al., 2010)
a. Importance of goal setting
b. Importance of interagency and interpersonal communication
c. Taking the time to coordinate all stakeholders
5. Poor communication and disagreements among caregivers along with overwhelming
responsibility (Lau, et al., 2010)
IV. Societal Perspective
A. Cancer Pain Management
Regarding morphine use in cancer care “ease the soul”… “relax”… “provide peace”… “ease
the journey”(Grant, et al., 2015)
1. Opiates and cancer pain hold notable social meanings built on meanings taken from film,
media, historical beliefs, and personal experience (Grant, et al., 2015)
2. Societal acceptance in use of opiate to treat cancer pain – helps patient achieve peace and
control (Grant, et al., 2015)
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3. Community perspective of use of opiates in cancer pain management are different than
myths commonly seen – barriers may be more reflective of the views of health
professionals (Grant, et al., 2015)
4. Health professionals should have controlled, responsible prescribing of opiates (Grant, et
al., 2015)
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Appendix B

Figure 1. “Truly Knowing the Patient” captures the significant characteristics of the patient –
clinician interaction from synthesis and interpretation of the qualitative literature.
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Figure 2. Components of a Good Quality of Life, a sub theme of Knowing the Patient, identifies
the characteristics of a what the individual with pain (whether or not there is SUD or life limiting
illness) considers necessary for good QOL as found in synthesis and interpretation of the
qualitative literature utilized in this project.

Running Head: PAIN MANAGEMENT AT END OF LIFE

69

Figure 3. Barriers to a Good Quality of Life, a sub theme of Knowing the Patient, identifies the
characteristics of a what the individual with SUD and pain (whether or not there is life limiting
illness) consider to be barriers to a good QOL as found in the synthesis and interpretation of the
qualitative literature utilized in this project.
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Figure 4. Fears from the perspectives of Patient, Nurse, Provider/Prescriber and Caregiver as
identified by the synthesis and interpretation of the qualitative literature utilized in this project.
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Figure 5. System Barriers to pain assessment and management and “knowing the patient” as
identified by the synthesis and interpretation of the qualitative literature utilized in this project.
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